-
Homepagina
-
Hip
-
Knee
-
Ankle
-
Shoulder
-
Elbow
-
Wrist
-
Finger
-
Data Quality
Revision within 11 years
Hip » Survival » Revision within 11 years » Overall
FIGURE Cumulative revision percentage of total hip arthroplasties by type of revision in the Netherlands in 2007-2019 (n=325,334)
TABLE Cumulative 11-years revision percentage
| Cumulative 11-year revision percentage | ||
| Competing Risk¹ (95% CI) | Kaplan Meier (95% CI) | |
| Any type of revision | 4.9 (4.8-5.0) | 5.3 (5.2-5.4) |
| Major revision² | 3.9 (3.8-4.0) | 4.3 (4.1-4.4) |
| Minor revision³ | 0.9 (0.9-1.0) | 1.0 (0.9-1.0) |
¹ The cumulative revision percentage using the competing risk method is shown in the figure.
2 Revision of at least the acetabulum or femur component.
3 Only inlay and/or femoral head exchange (including DAIR procedures).
CI: confidence interval.
© LROI 2020
In 2007-2019, 33,297 (10.8%) primary THAs were implanted in patients who died within eleven years after the primary diagnosis
Hip » Survival » Revision within 11 years » By gender
FIGURE Cumulative revision percentage of total hip arthroplasties by gender in the Netherlands in 2007-2019 (n=324,806)
TABLE Cumulative 11-years revision percentage
| Cumulative 11-year revision percentage | |||
| Number (n) | Competing Risk1 (95% CI) | Kaplan Meier (95% CI) | |
| Gender | |||
| Men | 109,609 | 5.4 (5.2-5.6) | 5.9 (5.7-6.1) |
| Women | 215,197 | 4.6 (4.5-4.8) | 5.0 (4.8-5.2) |
¹ The cumulative revision percentage using the competing risk method is shown in the figure.
CI: confidence interval.
© LROI 2020
Hip » Survival » Revision within 11 years » By age category
FIGURE Cumulative revision percentage of total hip arthroplasties by age category in the Netherlands in 2007-2019 (n=314,245)
TABLE Cumulative 11-years revision percentage
| Cumulative 11-year revision percentage | |||
| Number (n) | Competing Risk1 (95% CI) | Kaplan Meier (95% CI) | |
| Age (years) | |||
| <50 | 14,398 | 7.9 (7.2-8.7) | 8.1 (7.3-8.8) |
| 50-59 | 39,868 | 6.6 (6.2-7.0) | 6.7 (6.3-7.2) |
| 60-69 | 102,481 | 5.3 (5.1-5.5) | 5.6 (5.3-5.8) |
| 70-79 | 119,422 | 4.4 (4.2-4.6) | 4.8 (4.6-5.0) |
| ≥80 | 48,798 | 3.0 (2.8-3.2) | 3.4 (3.2-3.6) |
¹ The cumulative revision percentage using the competing risk method is shown in the figure.
CI: confidence interval.
© LROI 2020
Hip » Survival » Revision within 11 years » By diagnosis
FIGURE Cumulative revision percentage of total hip arthroplasties by diagnosis in the Netherlands in 2007-2019 (n=322,718)
TABLE Cumulative 11-years revision percentage
| Cumulative 11-year revision percentage | |||
| Number (n) | Competing Risk1 (95% CI) | Kaplan Meier (95% CI) | |
| Diagnosis | |||
| Osteoarthritis | 280,856 | 4.7 (4.6-4.8) | 5.1 (5.0-5.3) |
| Other | 41,862 | 5.9 (5.6-6.2) | 6.6 (6.2-7.0) |
¹ The cumulative revision percentage using the competing risk method is shown in the figure.
CI: confidence interval.
© LROI 2020
Hip » Survival » Revision within 11 years » By ASA score
FIGURE Cumulative revision percentage of total hip arthroplasties by ASA score in the Netherlands in 2007-2019 (n=305,156)
TABLE Cumulative 11-years revision percentage
| Cumulative 11-year revision percentage | |||
| Number (n) | Competing Risk1 (95% CI) | Kaplan Meier (95% CI) | |
| ASA score | |||
| I | 66,292 | 5.1 (4.9-5.4) | 5.3 (5.1-5.6) |
| II | 198,41 | 4.7 (4.6-4.9) | 5.1 (4.9-5.3) |
| III-IV | 50,686 | 4.6 (4.3-4.9) | 5.3 (4.9-5.7) |
¹ The cumulative revision percentage using the competing risk method is shown in the figure.
CI: confidence interval.
© LROI 2020